IMPROVED CLINICAL OUTCOMES FOR LIVER TRANSPLANT RECIPIENTS USING CYCLOSPORINE BLOOD LEVEL MONITORING BASED ON TWO‐HOUR POST‐DOSE LEVELS.: Abstract# 1059